Interview with Dr. Mikael Dolsten, Pfizer
Listen now
Description
Dr. Freire sits down with Dr. Mikael Dolsten, Chief Scientific Officer and President of Worldwide Research, Development and Medical of Pfizer, Inc. They explore the approach to and challenges associated with developing the Pfizer-BioNtech COVID 19 vaccine, research efforts on potential treatments and promising new therapeutics for the future.
More Episodes
Listen in as Dr. Maria Freire explores the work of Dr. Paul Stoffels, Johnson & Johnson’s Vice Chairman of the Executive Committee and Chief Scientific Officer, and his team as they have worked since April 2020 developing COVID-19 vaccines and monitoring emerging variants. Along with Dr....
Published 08/09/21
In this episode, Dr. Maria Freire sits down with Dr. Anne Schuchat, Principal Deputy Director of the Centers for Disease Control and Prevention. Learn how the CDC evaluates data when issuing guidance to the public, as well as its role in surveillance of new COVID-19 variants. According to Dr....
Published 06/03/21